Our findings of reduced expression levels of STIM1 and ORAI1 in MS patients suggest that while SARAF is elevated, the overall calcium signaling machinery may still be impaired, leading to a paradoxical state of increased calcium levels but dysfunctional signaling [17,27,28,29,30,31]. This evidence concerns the gene SARAF and myeloid sarcoma.